Braskem Pfd ADR Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Braskem Pfd ADR in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Braskem Pfd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Braskem Pfd ADR | - | - | - | - | - | - | - |
| Braskem Pfd A | 0.510% | 0.000% | -19.421% | 21.875% | 1.563% | -47.651% | -63.089% |
| Ingevity Corp | 1.340% | 6.966% | 2.374% | -30.481% | 4.766% | -24.639% | -55.463% |
| PTT Global Chemical -fgn- | -1.660% | -9.045% | -7.653% | -19.196% | -9.045% | -44.136% | -53.036% |
Comments
Braskem S.A. (NYSE: BAK) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was upgraded by analysts at Scotiabank from a "sector perform" rating to an "outperform" rating.
Show more
Ratings data for BAK provided by MarketBeat
Braskem S.A. (NYSE: BAK) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Show more
Ratings data for BAK provided by MarketBeat